BAC
56
3
STI
46
-3
PFE
38
-2
FAST
46
-2
EIX
61
2
MKC
41
-6
GIS
61
-2
OKE
67
2
MHK
50
2
NWS
83
2
ED
45
-3
WDC
55
5
SWN
57
5
DHI
52
2
TXN
52
9
AVGO
61
7
SWK
68
4
VFC
33
4
DE
42
3
QRVO
38
2
BAC
56
3
STI
46
-3
PFE
38
-2
FAST
46
-2
EIX
61
2
MKC
41
-6
GIS
61
-2
OKE
67
2
MHK
50
2
NWS
83
2
ED
45
-3
WDC
55
5
SWN
57
5
DHI
52
2
TXN
52
9
AVGO
61
7
SWK
68
4
VFC
33
4
DE
42
3
QRVO
38
2
Financhill
Back

OptimizeRx 10K Form

Sell
29

OPRX
OptimizeRx

Last Price:
13.13
Seasonality Move:
11.95%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2020-08-05 10Q OPRX/OptimizeRx Quarterly
2020-05-06 10Q OPRX/OptimizeRx Quarterly
2020-03-26 10K OPRX/OptimizeRx Annual
2019-11-05 10Q OPRX/OptimizeRx Quarterly
2019-08-07 10Q OPRX/OptimizeRx Quarterly
2019-05-08 10Q OPRX/OptimizeRx Quarterly

Receive OPRX News And Ratings

See the #1 stock for the next 7 days that we like better than OPRX

OPRX Financial Statistics

Sales & Book Value

Annual Sales: $62.45M
Cash Flow: $1.15M
Price / Cash Flow: 0
Annual Sales: $6.98
Price / Book: 1.51

Profitability

EPS (TTM): -0.80000
Net Income (TTM): $-13.75M
Gross Margin: $38.97M
Return on Equity: -11.24%
Return on Assets: -10.62%

OptimizeRx Earnings Forecast

Key OptimizeRx Financial Ratios

  • The Gross Profit Margin over the past 16 years for OPRX is 62.40%.
  • The Selling, General & Administrative Expenses for OPRX have been equal to 78.84% of Gross Profit Margin.
  • The Research & Development expenses have been 2.49% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of OPRX is -18.32% of Total Revenues.
  • Per Share Earnings over the last 16 years have been positive in 7 years.

OptimizeRx Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Technology
Sector: Health Care
Current Symbol: OPRX
CUSIP: 68401U
Website: optimizerx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 11.35
Quick Ratio: 10.96

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 18.27

OPRX Technical Analysis vs Fundamental Analysis

Sell
29
OptimizeRx (OPRX) is a Sell

Is OptimizeRx a Buy or a Sell?

  • OptimizeRx stock is rated a Sell
    The current OptimizeRx [OPRX] share price is $10.48. The Score for OPRX is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.